Online Menopause Treatment: The Telehealth Revolution Has Arrived

Getting a prescription for HRT used to require finding a doctor who knew menopause, scheduling an appointment three months out, sitting in a waiting room, and hoping the doctor didn’t dismiss your symptoms as “normal aging.” The telehealth boom changed this. Today you can complete a consultation, receive a prescription, and have medication shipped to your door without leaving your house — often within 48 hours.

The shift matters because the shortage of menopause-trained providers is real. The Menopause Society (formerly NAMS) lists roughly 1,700 certified menopause practitioners in the United States. For 63 million menopausal women. That’s one specialist per 37,000 women. Telehealth collapses this gap — the same certified practitioner can see patients in all 50 states through a video screen.

Four platforms dominate the market: Midi, Alloy, Evernow, and Hone Health. Each takes a different approach to pricing, insurance, and treatment philosophy. Here’s how they compare on the factors that actually matter. For a full overview of your options, read our complete guide to menopause treatment.

Midi Health: The Most Comprehensive Option

Midi Health, founded in 2021 and based in San Francisco, is the closest thing to a full-service women’s midlife clinic that exists entirely online. Unlike platforms that focus narrowly on HRT prescriptions, Midi treats the full spectrum of perimenopause and menopause concerns — hot flashes, night sweats, sleep disruption, mood changes, vaginal symptoms, weight changes, thyroid issues, and sexual health.

The clinical model sets Midi apart. Consultations are with menopause-trained practitioners — nurse practitioners and physicians with specific expertise in midlife women’s health, not general practitioners working a telehealth side gig. The initial visit runs roughly 30 to 45 minutes, far longer than the 10-minute rush typical of in-network primary care appointments.

Midi’s biggest advantage is insurance acceptance. The platform is in-network with most PPO plans across major insurers. For women with commercial insurance, the visit cost is typically a standard copay of $20 to $60. Without insurance, the self-pay rate is $249 for an initial visit and $99 for follow-ups. Prescriptions are sent to your local pharmacy and filled through your insurance drug plan — no forced pharmacy markups.

The downside: Midi’s availability varies by state. As of early 2026, the platform is live in roughly 40 states and expanding. If you live in a state Midi doesn’t yet cover, you’ll need one of the alternatives below.

Alloy: Fast, Simple, and Subscription-Free

Alloy takes a different approach. The initial consultation costs $49 — no insurance needed. You complete a medical assessment in about three minutes, then a menopause-trained physician reviews your history and prescribes treatment through Alloy’s secure portal. The process from sign-up to prescription typically takes 24 hours.

Alloy doesn’t accept insurance for consultations, but it does submit claims for prescription medications if your plan covers them. For women without insurance, Alloy offers a “Membership” program that delivers a three-month supply of estradiol patch and oral progesterone for $220 — roughly $73 per month. That’s competitive with out-of-pocket pharmacy pricing for brand-name products.

Alloy’s product range is narrower than Midi’s. The focus is on FDA-approved HRT — patches, creams, and oral medications — plus a few support products like vaginal moisturizers and facial creams. There’s no weight management or thyroid care. But for straightforward HRT, Alloy’s speed and simplicity are hard to beat. The $49 consultation fee is the cheapest entry point among the major platforms, and the turnaround time is the fastest.

Evernow: Monthly Membership Model

Evernow, founded by a Stanford-trained physician, operates on a membership model. You pay a recurring monthly fee — typically $19 to $49 depending on the plan — which covers unlimited messaging with a clinician and prescription management. Initial consultations are free, and Evernow accepts insurance for medication costs.

The Evernow advantage is ongoing support. The membership model means you can message your provider with questions, symptom changes, or side effects without scheduling a full appointment. For women who need frequent dose adjustments during the first few months of HRT, this is valuable. The average HRT user needs two to three dose adjustments in the first six months. A membership model makes those adjustments frictionless.

Evernow prescribes both FDA-approved HRT and compounded bioidentical hormones, which sets it apart from Midi and Alloy. Compounded hormones are custom-mixed at a compounding pharmacy and aren’t FDA-approved — The Menopause Society advises caution with compounding because of inconsistent dosing and lack of quality control. If you want FDA-approved products only, this may not matter, but for women who prefer a custom formulation, it’s a distinguishing feature.

The trade-off is cost. At $49 per month plus medication costs, Evernow can become expensive over time. A year of membership at $49/month costs $588 before any prescription costs. Compare this to Alloy’s one-time $49 fee or Midi’s insurance-covered copays, and the membership model makes most sense for women who anticipate needing ongoing medical support beyond simple prescription refills.

Hone Health: The Hormone Optimization Angle

Hone Health positions itself as a longevity and hormone optimization clinic rather than a dedicated menopause service. This broader framing means Hone treats both men and women, covering testosterone therapy alongside estrogen replacement. For women with low libido that persists after standard HRT, Hone’s testosterone offerings are relevant — testosterone therapy for women is off-label in the United States but has growing clinical support.

Hone’s model requires joining one of two tiers: a standard membership at roughly $120 to $150 per visit or an annual plan. Blood testing is built into the process — Hone sends you a lab kit, you provide a finger-prick sample or visit a local LabCorp, and results are reviewed by a physician before treatment begins. This appeals to women who want objective hormone data before starting therapy.

The downside is cost and convenience. Hone’s per-visit cost is higher than Alloy’s $49 fee, and blood testing adds another step to the process. For straightforward estrogen replacement where blood tests aren’t clinically necessary (menopause is diagnosed by symptoms and age, not lab values), Hone adds complexity without added value. But for women with complex hormone issues or persistent symptoms after standard treatment, the deeper diagnostic approach can identify problems that simpler platforms miss.

Comparing the Four: A Decision Framework

Here’s the decision framework at a glance:

Have PPO insurance? Start with Midi. Insurance-covered care is almost always the most cost-effective option. Check state availability first.
No insurance or Midi unavailable? Choose Alloy for straightforward HRT. $49 consultation. 24-hour turnaround to prescription.
Need ongoing dose adjustments? Evernow’s membership model ($19-$49/month) provides better continuity for changing symptoms during early perimenopause.
Still feel off on standard HRT? Hone Health’s broader panel, including testosterone assessment, can identify issues simpler platforms miss.

For a more detailed look at what HRT involves and which hormone therapy options are available, read our guide on hormone replacement therapy.

What Telehealth Can’t Do

Online menopause treatment has real limitations. No telehealth platform can perform a pelvic exam, take a Pap smear, assess vaginal atrophy through a physical examination, or monitor endometrial thickness with ultrasound. If you have unexpected vaginal bleeding, pelvic pain, or a personal or family history of hormone-sensitive cancers, you need an in-person gynecologist — not a video call.

Telehealth is appropriate for healthy women with uncomplicated menopause whose symptoms are manageable with standard therapies. The 2024 European Society of Endocrinology clinical practice guideline supports this: most women can initiate HRT without a pelvic exam or mammogram beforehand, provided they’re up to date with routine screening. But established patients need ongoing in-person care for breast cancer screening, bone density monitoring, and cardiovascular risk assessment.

Think of telehealth as the front door — fast, convenient, and good for the first step. In-person care is the house — necessary for the full picture of your health. The best approach uses both. Start your search for menopause treatment on our homepage.

The Bottom Line

Online menopause treatment has transformed access to care. For the 40% of women who live in counties without a single menopause-certified practitioner, telehealth is the difference between treatment and silence. Midi leads on comprehensiveness and insurance coverage. Alloy leads on speed and low cost. Evernow leads on continuity and support. Hone leads on diagnostic depth and hormone optimization.

Choose based on your specific needs: insurance status, symptom complexity, and how much ongoing provider support you want. Any of the four is better than suffering through symptoms without treatment.